| Patient-related factors |
r |
p value |
Infusion-related factors |
r |
p value |
| Age |
0.231 |
0.071 |
Dose |
-0.113 |
0.358 |
| Gender |
0.226 |
0.077 |
Dosing regimen |
0.263* |
0.039 |
| Presence of one or more risk factors |
0.243* |
0.029 |
Course duration (days) |
0.113 |
0.503 |
| Primary Immunodeficiency |
-0.442** |
0.000 |
Infusion hours (actual) |
-0.111 |
0.826 |
| Auto-immunity |
0.203 |
0.113 |
Infusion hours(intended) |
0.116 |
0.370 |
| Nephrotoxic drugs |
0.389** |
0.002 |
Infusion rate |
0.112 |
0.317 |
| Infection |
-0.175 |
0.174 |
IVIG Preparation |
0.376** |
0.003 |
| Allergy |
0.313* |
0.013 |
Final infusion diagnosis |
0.269* |
0.035 |
| Pre-existing renal insufficiency |
-0.062 |
0.633 |
FDA approval |
-0.384** |
0.002 |
*Correlation is significant at 0.05 levels (2-tailed)
**Correlation is significant at 0.01 levels (2-tailed) |
|
